JP2005524627A5 - - Google Patents

Download PDF

Info

Publication number
JP2005524627A5
JP2005524627A5 JP2003562091A JP2003562091A JP2005524627A5 JP 2005524627 A5 JP2005524627 A5 JP 2005524627A5 JP 2003562091 A JP2003562091 A JP 2003562091A JP 2003562091 A JP2003562091 A JP 2003562091A JP 2005524627 A5 JP2005524627 A5 JP 2005524627A5
Authority
JP
Japan
Prior art keywords
dihydropyrimidine
oxo
methyl
ethynyl
trimethylsilyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003562091A
Other languages
English (en)
Japanese (ja)
Other versions
JP4498745B2 (ja
JP2005524627A (ja
Filing date
Publication date
Priority claimed from GBGB0201179.9A external-priority patent/GB0201179D0/en
Application filed filed Critical
Publication of JP2005524627A publication Critical patent/JP2005524627A/ja
Publication of JP2005524627A5 publication Critical patent/JP2005524627A5/ja
Application granted granted Critical
Publication of JP4498745B2 publication Critical patent/JP4498745B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003562091A 2002-01-18 2003-01-15 ピリミジノンウイルスポリメラーゼ阻害剤 Expired - Fee Related JP4498745B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201179.9A GB0201179D0 (en) 2002-01-18 2002-01-18 Therapeutic agents
PCT/GB2003/000124 WO2003062211A1 (en) 2002-01-18 2003-01-15 Pyrimidinone viral polymerase inhibitors

Publications (3)

Publication Number Publication Date
JP2005524627A JP2005524627A (ja) 2005-08-18
JP2005524627A5 true JP2005524627A5 (cg-RX-API-DMAC7.html) 2010-02-04
JP4498745B2 JP4498745B2 (ja) 2010-07-07

Family

ID=9929352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003562091A Expired - Fee Related JP4498745B2 (ja) 2002-01-18 2003-01-15 ピリミジノンウイルスポリメラーゼ阻害剤

Country Status (8)

Country Link
US (1) US20050130997A1 (cg-RX-API-DMAC7.html)
EP (1) EP1470113B1 (cg-RX-API-DMAC7.html)
JP (1) JP4498745B2 (cg-RX-API-DMAC7.html)
AT (1) ATE420078T1 (cg-RX-API-DMAC7.html)
CA (1) CA2473508A1 (cg-RX-API-DMAC7.html)
DE (1) DE60325692D1 (cg-RX-API-DMAC7.html)
GB (1) GB0201179D0 (cg-RX-API-DMAC7.html)
WO (1) WO2003062211A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062613A2 (en) 2003-01-13 2004-07-29 Bristol-Myers Squibb Company Hiv integrase inhibitors
ATE478886T1 (de) 2003-07-25 2010-09-15 Idenix Pharmaceuticals Inc Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
WO2005016384A1 (ja) * 2003-08-13 2005-02-24 Bf Research Institute, Inc. アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤
AR046938A1 (es) * 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
CN1922174A (zh) 2004-02-20 2007-02-28 贝林格尔·英格海姆国际有限公司 病毒聚合酶抑制剂
AU2006242475B2 (en) 2005-05-02 2011-07-07 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
AR057456A1 (es) 2005-07-20 2007-12-05 Merck & Co Inc Inhibidores de la proteasa ns3 del vhc
US8278322B2 (en) 2005-08-01 2012-10-02 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
JP5094725B2 (ja) * 2005-10-04 2012-12-12 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ Hivインテグラーゼ阻害剤
GB0609492D0 (en) 2006-05-15 2006-06-21 Angeletti P Ist Richerche Bio Therapeutic agents
GB0612423D0 (en) 2006-06-23 2006-08-02 Angeletti P Ist Richerche Bio Therapeutic agents
US8138164B2 (en) 2006-10-24 2012-03-20 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
CN101583372A (zh) 2006-10-24 2009-11-18 默克公司 Hcv ns3蛋白酶抑制剂
CA2667165A1 (en) 2006-10-24 2008-05-02 Merck & Co., Inc. Hcv ns3 protease inhibitors
WO2008057208A2 (en) 2006-10-27 2008-05-15 Merck & Co., Inc. Hcv ns3 protease inhibitors
JP5268927B2 (ja) 2006-10-27 2013-08-21 メルク・シャープ・アンド・ドーム・コーポレーション Hcvns3プロテアーゼ阻害剤
US8101595B2 (en) 2006-12-20 2012-01-24 Istituto di Ricerche di Biologia Molecolare P. Angletti SpA Antiviral indoles
GB0625349D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
GB0625345D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
MX2009011930A (es) 2007-05-04 2009-11-18 Vertex Pharma Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
US7763630B2 (en) 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
AU2008277442A1 (en) 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis C infections
CN101754974B (zh) 2007-07-19 2016-02-03 Msd意大利有限公司 作为抗病毒剂的大环化合物
WO2009018657A1 (en) * 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP2234977A4 (en) 2007-12-19 2011-04-13 Boehringer Ingelheim Int VIRAL POLYMERASE INHIBITORS
CN102014911A (zh) 2008-04-28 2011-04-13 默沙东公司 Hcv ns3蛋白酶抑制剂
ES2392611T3 (es) 2008-07-22 2012-12-12 Merck Sharp & Dohme Corp. Compuestos de quinoxalina macrocíclica como inhibidores de la proteasa NS3 del VHC
KR20110116136A (ko) 2009-01-07 2011-10-25 싸이넥시스, 인크. Hcv 및 hiv 감염의 치료에 사용하기 위한 사이클로스포린 유도체
AU2010210426B2 (en) * 2009-02-06 2015-06-11 Imago Pharmaceuticals, Inc. Inhibitors of Jun N-terminal kinase
US8143244B2 (en) 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
RU2552533C2 (ru) * 2009-03-25 2015-06-10 Эббви Инк. Противовирусные соединения и их применения
US8828930B2 (en) 2009-07-30 2014-09-09 Merck Sharp & Dohme Corp. Hepatitis C virus NS3 protease inhibitors
US8383639B2 (en) 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
RU2572835C2 (ru) * 2010-08-13 2016-01-20 Ф. Хоффманн-Ля Рош Аг Производные (4-метилсульфониламинофенил)-хинолина, полезные при лечении гепатита с
WO2012151567A1 (en) * 2011-05-05 2012-11-08 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
DE19817265A1 (de) * 1998-04-18 1999-10-21 Bayer Ag Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe
WO2000013708A1 (en) * 1998-09-04 2000-03-16 Viropharma Incorporated Methods for treating or preventing viral infections and associated diseases
GB0017676D0 (en) * 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase

Similar Documents

Publication Publication Date Title
JP2801330B2 (ja) メタクリロキシ基又はアクリロキシ基を含むオルガノシランの製法
CN1582272A (zh) 制备5-(3-氰基苯基)-3-甲酰基苯甲酸化合物的方法
JP2011514871A5 (cg-RX-API-DMAC7.html)
JP4377594B2 (ja) β−アルコキシプロピオンアミド類の製造方法
CN114573512B (zh) 一种合成c2-二氟烷基苯并咪唑衍生物的方法
JP5669984B2 (ja) 5−アザスピロ[2.4]ヘプタン−6−カルボン酸およびその誘導体の製造方法
JP2008201739A (ja) エダラボンの製造方法
JP2008088172A (ja) フェニルテトラゾール化合物の製法
JP2003212823A5 (cg-RX-API-DMAC7.html)
JP2005516905A5 (cg-RX-API-DMAC7.html)
CN101646643B (zh) 交叉偶联化合物的制造方法
JP4055433B2 (ja) 嵩高い置換基を有するシリル(メタ)アクリレート化合物及びその製造方法
CN101061128A (zh) 制备二异丙基((1-(羟甲基)-环丙基)氧)甲基膦酸脂的方法
JPH051000A (ja) シクロヘキシル酪酸誘導体及びその製造法
CN1314673C (zh) 具有手性的多齿噁唑啉配体及其与主族金属或过渡金属的配合物、合成方法及其用途
JP5129699B2 (ja) メチル=ヘキサデカ−8−イノアートの製造方法
CN1642964A (zh) 铜络合物和利用该铜络合物形成含铜薄膜的方法
CN103249714B (zh) 山椒素类的制造方法
JP2004535444A5 (cg-RX-API-DMAC7.html)
JP2003201281A (ja) 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法
CN113861167A (zh) 富马酸伏诺拉生的制备方法
CN115594621B (zh) 一种二硒醚类化合物的球磨机械化学合成方法
WO2004024672A1 (ja) アミン誘導体
JP3895053B2 (ja) ジハロメチルシラン類の製法
CN1173986C (zh) 一种高碳糖的合成方法